Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by charlierockon Nov 20, 2024 11:31am
161 Views
Post# 36321822

RE:RE:RE:RE:RE:2025 Outlook

RE:RE:RE:RE:RE:2025 Outlook Lots of discussion regarding JV, buyouts etc which is fun to speculate about, however none of this happens until we get BTD. Personally I think TLT should be granted BTD and AA based on the fact that the data shows us superior to anything else out there including zero side effects, relative low cost and the dire need for an effective treatment.
I really don't like an outside authority ( the FDA) having our fate in their hands at least for the short term but nothing can be done about that. It's pressure time but this is the position we wanted to be in. This is what we signed up for. To quote Billie Jean King-"Pressure is a privilege "
<< Previous
Bullboard Posts
Next >>